Orthopedic Procedures and Postoperative Delirium in Older Adults in the Czech Republic

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorTomas Bata Hospital, Czech Republic

About this trial

This multicenter, prospective, non-interventional observational study (ORTOPODCZ) investigates the association between preoperative cognitive impairment and postoperative delirium (POD) in older adults undergoing elective total hip arthroplasty in the Czech Republic. Postoperative delirium is a frequent and serious neurocognitive complication in senior surgical patients and is associated with increased morbidity, mortality, prolonged hospitalization, and impaired functional and cognitive outcomes. Despite international recommendations, routine preoperative cognitive screening remains insufficiently implemented.

The study evaluates the predictive value of the ALBA test, a brief cognitive screening tool, performed during the pre-anesthetic assessment. Postoperative delirium will be assessed using the validated CAM-ICU instrument for up to 72 hours after surgery. Secondary objectives include assessing the relationship between POD and frailty, polypharmacy, comorbidities, type of anesthesia, intraoperative hemodynamics, blood loss, vasoactive support, and postoperative complications.

Approximately 300-400 participants aged ≥65 years will be enrolled across seven centers. No additional procedures, biological sampling, or deviations from standard clinical care are required. Data will be collected in REDCap and analyzed according to a predefined statistical analysis plan. The study aims to provide robust evidence supporting the integration of cognitive screening into routine preoperative evaluation and to describe feasibility and implementation requirements for the ALBA test in clinical practice.

Eligibility criteria

Qualifiers

Age ≥ 65 years

Elective total hip arthroplasty in general or regional anesthesia

ASA physical status I-III

Ability to understand and cooperate during testing; no severe sensory impairment (compensatory aids allowed)

Disqualifiers

Glasgow Coma Scale ≤ 14

Limited legal capacity

Active psychiatric disorder (e.g., psychotic disorder, bipolar disorder)

Active oncological disease

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

400 Participants
are grouped into 1 trial group

Sponsors and collaborators

Tomas Bata Hospital, Czech Republic

Lead sponsor

Czech Clinical Research Infrastructure Network

Collaborator